[HTML][HTML] Cardiovascular risk factors and prevention: a perspective from develo** countries

KK Teo, T Rafiq - Canadian journal of cardiology, 2021 - Elsevier
By the beginning of the 21st century, cardiovascular disease (CVD) had become the leading
cause of premature mortality and morbidity worldwide, with 80% originating from less …

Cardiovascular risks associated with gender and aging

JL Rodgers, J Jones, SI Bolleddu… - Journal of …, 2019 - mdpi.com
The aging and elderly population are particularly susceptible to cardiovascular disease. Age
is an independent risk factor for cardiovascular disease (CVD) in adults, but these risks are …

Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study

R Quispe, SS Martin, ED Michos, I Lamba… - European heart …, 2021 - academic.oup.com
Aims Emerging evidence suggests that remnant cholesterol (RC) promotes atherosclerotic
cardiovascular disease (ASCVD). We aimed to estimate RC-related risk beyond low-density …

2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force …

DK Arnett, RS Blumenthal, MA Albert… - Journal of the American …, 2019 - jacc.org
Although there has been substantial improvement in atherosclerotic cardiovascular disease
(ASCVD) outcomes in recent decades, ASCVD remains the leading cause of morbidity and …

Chronic kidney disease diagnosis and management: a review

TK Chen, DH Knicely, ME Grams - Jama, 2019 - jamanetwork.com
Importance Chronic kidney disease (CKD) is the 16th leading cause of years of life lost
worldwide. Appropriate screening, diagnosis, and management by primary care clinicians …

Coronary calcium score and cardiovascular risk

P Greenland, MJ Blaha, MJ Budoff, R Erbel… - Journal of the American …, 2018 - jacc.org
Coronary artery calcium (CAC) is a highly specific feature of coronary atherosclerosis. On
the basis of single-center and multicenter clinical and population-based studies with short …

Use of Lipoprotein (a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association

DP Wilson, TA Jacobson, PH Jones… - Journal of clinical …, 2019 - Elsevier
Abstract Lipoprotein (a)[Lp (a)] is a well-recognized, independent risk factor for
atherosclerotic cardiovascular disease, with elevated levels estimated to be prevalent in …

Effects of stress on the development and progression of cardiovascular disease

M Kivimäki, A Steptoe - Nature Reviews Cardiology, 2018 - nature.com
Cardiovascular disease remains the leading cause of disease burden globally, which
underlies the continuing need to identify new complementary targets for prevention. Over the …

DASH dietary pattern and cardiometabolic outcomes: an umbrella review of systematic reviews and meta-analyses

L Chiavaroli, E Viguiliouk, SK Nishi, S Blanco Mejia… - Nutrients, 2019 - mdpi.com
Background: The Dietary Approaches to Stop Hypertension (DASH) dietary pattern, which
emphasizes fruit, vegetables, fat-free/low-fat dairy, whole grains, nuts and legumes, and …

Apolipoprotein B and non-HDL cholesterol better reflect residual risk than LDL cholesterol in statin-treated patients

CDL Johannesen, MB Mortensen, A Langsted… - Journal of the American …, 2021 - jacc.org
Background In cholesterol guidelines, low-density lipoprotein (LDL) cholesterol remains the
primary target while apolipoprotein B (apoB) and non–high-density lipoprotein (non-HDL) …